Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

AH-001 could be a safer and more effective treatment for hair loss.

Computational techniques can improve drug development for treating certain conditions.

Rituximab effectively treated a woman's bone lymphoma that was resistant to other treatments.

The FDA approved a new Pfizer drug for hair loss in teens.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

A compound from brown algae boosts the production of a certain inflammatory substance in skin cells.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Ocu-miR-205 helps control hair growth in Rex rabbits by affecting cell processes and signaling pathways.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

Ixekizumab is safe for long-term use with low rates of major heart-related events.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Higher doses of Tribulus terrestris extract increase MC-1R expression in mouse hair follicles.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

RhoA helps skin stem cells grow, aiding wound healing.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Spanlastics effectively deliver Rizatriptan Benzoate with high efficiency and controlled release.